Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pathetic disinterest in the stock. One day away from the Markman hearing

"... responsibility of the Executives of the Company to tell the story, to tell investors the benefits of Stock ownership, and to demonstrate confidence in their own Leadership ..."

The world of patents doesn't change even if you insist on your world view.

There is no story that can be told reliable as long as the patents are not confirmed 1,000% valid and powerful = second Markman and maybe the trail with the T3.

There is no benefit of stock ownership as long as no money is coming in from the patents.

And as long there is no money there is no need for leadership (therefore it's entireley sufficient to have an Interim CEO).

So it's more pathetic to repeat this old stuff of the inept BoD on a regular basis but, hey, if it makes you feel better - go for it...lol


Share
New Message
Please login to post a reply